SkinHealth Systems (SKIN) Research & Development (2020 - 2026)

SkinHealth Systems (SKIN) has 7 years of Research & Development data on file, last reported at $1.1 million in Q1 2026.

• Research & Development for Q1 2026 came in at $1.1 million, up 10.42% year-over-year; the trailing twelve-month figure through Mar 2026 was $5.7 million (up 27.75% YoY), and the FY2025 annual result was $5.6 million, down 10.61% from the prior year.
• Research & Development fell to $1.1 million in Q1 2026 per SKIN's latest filing, from $1.7 million in the prior quarter.
• Over five years, Research & Development peaked at $3.0 million in Q4 2023 and troughed at $998000.0 in Q1 2025.
• A 5-year average of $1.9 million and a median of $1.7 million in 2025 frame the typical range for Research & Development.
• The sharpest annual moves came in 2023 and 2025: Research & Development soared 110.65% in 2023, then tumbled 64.45% in 2025.
• A 5-year view of Research & Development shows it stood at $1.4 million in 2022, then soared by 110.65% to $3.0 million in 2023, then sank by 59.88% to $1.2 million in 2024, then soared by 37.56% to $1.7 million in 2025, then plunged by 34.44% to $1.1 million in 2026.
• Business Quant data shows SKIN's Research & Development at $1.1 million in Q1 2026, $1.7 million in Q4 2025, and $1.7 million in Q3 2025.